ConductScience.org, home

Library / Genes

B3GAT1: beta-1,3-glucuronyltransferase 1

1 protein, 41 patents, 0 drugs, 0 trials, 4,304 NIH grants and 10,284 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolB3GAT1HGNC
Namebeta-1,3-glucuronyltransferase 1HGNC
NCBI Gene ID27087NCBI Gene
HGNC IDHGNC:921HGNC
EnsemblENSG00000109956NCBI Gene
AliasesCD57, GLCATP, GLCUATP, GlcAT-P, HNK1, LEU7, NK-1, NK1NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q9P2W7Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 13343Ensembl, GeneID, HGNCUniProt

Patents 41

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1438956Q9P2W7Espacenet
JP 2026004568 A2026-01-1438957Q9P2W7Espacenet
JP 2026004568 A2026-01-1438958Q9P2W7Espacenet
EP 4641201 A22025-10-294082Q9P2W7Espacenet
JP 2025517969 A2025-06-124082Q9P2W7Espacenet
WO 2025093745 A12025-05-0867Q9P2W7Espacenet
JP 2025062604 A2025-04-148968Q9P2W7Espacenet
JP 2025062604 A2025-04-148969Q9P2W7Espacenet
JP 2025062604 A2025-04-148970Q9P2W7Espacenet
JP 2025502844 A2025-01-2822Q9P2W7Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 4304

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30AI027763UCSF-Bay Area Center for AIDS Research582,025NIH's project files
P30CA016672Cancer Center Support Grant502,025NIH's project files
P30CA008748Cancer Center Support Grant432,025NIH's project files
P01CA111412NK cells, their receptors and cancer therapy412,025NIH's project files
P01CA065493Off-the-Shelf Immune Effector Cells for Hematological Malignancies392,025NIH's project files
P30CA013148Comprehensive Cancer Center Support Grant322,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award222,025NIH's project files
UM1AI068636Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections222,025NIH's project files
P30CA077598Cancer Center Support Grant212,025NIH's project files
U19AI057229Understanding Influenza and SARS-CoV-2 vaccine responses, in vivo and in vitro212,025NIH's project files

Papers 10284

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42823801PubTator, text miningPubMed
42814514PubTator, text miningPubMed
42800594PubTator, text miningPubMed
42797773PubTator, text miningPubMed
42779738PubTator, text miningPubMed
42775700PubTator, text miningPubMed
42760285PubTator, text miningPubMed
42755799PubTator, text miningPubMed
42751476PubTator, text miningPubMed
42710178PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license